Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector

Limb-girdle muscular dystrophies 2C–F represent a family of autosomal recessive diseases caused by defects in sarcoglycan genes 1 . The cardiomyopathic hamster is a naturally occurring model for limb-girdle muscular dystrophy caused by a primary deficiency in δ-sarcoglycan 2 , 3 , 4 , 5 . We show he...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature medicine 1999-04, Vol.5 (4), p.439-443
Hauptverfasser: Greelish, James P., Su, Leonard T., Lankford, Edward B., Burkman, James M., Chen, Haiyan, Konig, Stephane K., Mercier, Isabelle M., Desjardins, Philippe R., Mitchell, Marilyn A., Zheng, Xiang guang, Leferovich, John, Gao, Guang Ping, Balice-Gordon, Rita J., Wilson, James M., Stedman, Hansell H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 443
container_issue 4
container_start_page 439
container_title Nature medicine
container_volume 5
creator Greelish, James P.
Su, Leonard T.
Lankford, Edward B.
Burkman, James M.
Chen, Haiyan
Konig, Stephane K.
Mercier, Isabelle M.
Desjardins, Philippe R.
Mitchell, Marilyn A.
Zheng, Xiang guang
Leferovich, John
Gao, Guang Ping
Balice-Gordon, Rita J.
Wilson, James M.
Stedman, Hansell H.
description Limb-girdle muscular dystrophies 2C–F represent a family of autosomal recessive diseases caused by defects in sarcoglycan genes 1 . The cardiomyopathic hamster is a naturally occurring model for limb-girdle muscular dystrophy caused by a primary deficiency in δ-sarcoglycan 2 , 3 , 4 , 5 . We show here that acute sarcolemmal disruption occurs in this animal model during forceful muscle contraction. A recombinant adeno-associated virus vector encoding human δ-sarcoglycan conferred efficient and stable genetic reconstitution in the adult cardiomyopathic hamster when injected directly into muscle. A quantitative assay demonstrated that vector-transduced muscle fibers are stably protected from sarcolemmal disruption; there was no associated inflammation or immunologic response to the vector-encoded protein. Efficient gene transduction with rescue of the sarcoglycan complex in muscle fibers of the distal hindlimb was also obtained after infusion of recombinant adeno-associated virus into the femoral artery in conjunction with histamine-induced endothelial permeabilization. This study provides a strong rationale for the development of gene therapy for limb-girdle muscular dystrophy.
doi_str_mv 10.1038/7439
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69686199</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17222219</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-79bbf4f866d71d20442e252e900b976a054b704b974ab26a07af668e0c6b01b23</originalsourceid><addsrcrecordid>eNqFkc1u1TAQhS1ERUvLKyAvgF3o2EmceImq8iNVYgFI7KKxM-l1ldjBdgr3FfrU9dXtAlZ447HmO2fkOYxdCHgvoO4vu6bWz9iZaBtViQ5-Pi81dH3V61adspcp3QFADa1-wU4FSJC6Vmfs4VtGMxOPlHKImF3wPEw874gnjDbcznuLntuwrDP94c7zcZ9yDOvOWb5syRbtSnHaEo38t8s7vnMp4-I8cfQjx-JcxMZ59JnjSD5UmFKwDnNR3LuIM78nW4ZfsJMJ50Svnu5z9uPj9ferz9XN109frj7cVLauZa46bczUTL1SYydGCU0jSbaSNIDRnUJoG9NBU-oGjSzvDielegKrDAgj63P27ui7xvBrK_8eFpcszTN6ClsalFa9Elr_FxSdLEccwDdH0MaQUqRpWKNbMO4HAcMhnOEQTsFeP_ltZqHxL-iYRgHeHoFUWv6W4nAXtujLMv41egSKx5eP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17222219</pqid></control><display><type>article</type><title>Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Springer Nature - Connect here FIRST to enable access</source><creator>Greelish, James P. ; Su, Leonard T. ; Lankford, Edward B. ; Burkman, James M. ; Chen, Haiyan ; Konig, Stephane K. ; Mercier, Isabelle M. ; Desjardins, Philippe R. ; Mitchell, Marilyn A. ; Zheng, Xiang guang ; Leferovich, John ; Gao, Guang Ping ; Balice-Gordon, Rita J. ; Wilson, James M. ; Stedman, Hansell H.</creator><creatorcontrib>Greelish, James P. ; Su, Leonard T. ; Lankford, Edward B. ; Burkman, James M. ; Chen, Haiyan ; Konig, Stephane K. ; Mercier, Isabelle M. ; Desjardins, Philippe R. ; Mitchell, Marilyn A. ; Zheng, Xiang guang ; Leferovich, John ; Gao, Guang Ping ; Balice-Gordon, Rita J. ; Wilson, James M. ; Stedman, Hansell H.</creatorcontrib><description>Limb-girdle muscular dystrophies 2C–F represent a family of autosomal recessive diseases caused by defects in sarcoglycan genes 1 . The cardiomyopathic hamster is a naturally occurring model for limb-girdle muscular dystrophy caused by a primary deficiency in δ-sarcoglycan 2 , 3 , 4 , 5 . We show here that acute sarcolemmal disruption occurs in this animal model during forceful muscle contraction. A recombinant adeno-associated virus vector encoding human δ-sarcoglycan conferred efficient and stable genetic reconstitution in the adult cardiomyopathic hamster when injected directly into muscle. A quantitative assay demonstrated that vector-transduced muscle fibers are stably protected from sarcolemmal disruption; there was no associated inflammation or immunologic response to the vector-encoded protein. Efficient gene transduction with rescue of the sarcoglycan complex in muscle fibers of the distal hindlimb was also obtained after infusion of recombinant adeno-associated virus into the femoral artery in conjunction with histamine-induced endothelial permeabilization. This study provides a strong rationale for the development of gene therapy for limb-girdle muscular dystrophy.</description><identifier>ISSN: 1078-8956</identifier><identifier>EISSN: 1546-170X</identifier><identifier>DOI: 10.1038/7439</identifier><identifier>PMID: 10202936</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>Adeno-associated virus ; Animals ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Cell Membrane Permeability ; Cricetinae ; Cytoskeletal Proteins - genetics ; Cytoskeletal Proteins - therapeutic use ; Dependovirus - genetics ; Genetic Therapy - methods ; Genetic Vectors ; Histamine - therapeutic use ; Humans ; Infectious Diseases ; Membrane Glycoproteins - genetics ; Membrane Glycoproteins - therapeutic use ; Metabolic Diseases ; Molecular Medicine ; Muscular Dystrophy, Animal - therapy ; Neurosciences ; Perfusion ; Rats ; Rats, Inbred F344 ; Recombinant Proteins - therapeutic use ; Sarcoglycans ; Sarcolemma - pathology</subject><ispartof>Nature medicine, 1999-04, Vol.5 (4), p.439-443</ispartof><rights>Nature America Inc. 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-79bbf4f866d71d20442e252e900b976a054b704b974ab26a07af668e0c6b01b23</citedby><cites>FETCH-LOGICAL-c332t-79bbf4f866d71d20442e252e900b976a054b704b974ab26a07af668e0c6b01b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/7439$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/7439$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10202936$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Greelish, James P.</creatorcontrib><creatorcontrib>Su, Leonard T.</creatorcontrib><creatorcontrib>Lankford, Edward B.</creatorcontrib><creatorcontrib>Burkman, James M.</creatorcontrib><creatorcontrib>Chen, Haiyan</creatorcontrib><creatorcontrib>Konig, Stephane K.</creatorcontrib><creatorcontrib>Mercier, Isabelle M.</creatorcontrib><creatorcontrib>Desjardins, Philippe R.</creatorcontrib><creatorcontrib>Mitchell, Marilyn A.</creatorcontrib><creatorcontrib>Zheng, Xiang guang</creatorcontrib><creatorcontrib>Leferovich, John</creatorcontrib><creatorcontrib>Gao, Guang Ping</creatorcontrib><creatorcontrib>Balice-Gordon, Rita J.</creatorcontrib><creatorcontrib>Wilson, James M.</creatorcontrib><creatorcontrib>Stedman, Hansell H.</creatorcontrib><title>Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector</title><title>Nature medicine</title><addtitle>Nat Med</addtitle><addtitle>Nat Med</addtitle><description>Limb-girdle muscular dystrophies 2C–F represent a family of autosomal recessive diseases caused by defects in sarcoglycan genes 1 . The cardiomyopathic hamster is a naturally occurring model for limb-girdle muscular dystrophy caused by a primary deficiency in δ-sarcoglycan 2 , 3 , 4 , 5 . We show here that acute sarcolemmal disruption occurs in this animal model during forceful muscle contraction. A recombinant adeno-associated virus vector encoding human δ-sarcoglycan conferred efficient and stable genetic reconstitution in the adult cardiomyopathic hamster when injected directly into muscle. A quantitative assay demonstrated that vector-transduced muscle fibers are stably protected from sarcolemmal disruption; there was no associated inflammation or immunologic response to the vector-encoded protein. Efficient gene transduction with rescue of the sarcoglycan complex in muscle fibers of the distal hindlimb was also obtained after infusion of recombinant adeno-associated virus into the femoral artery in conjunction with histamine-induced endothelial permeabilization. This study provides a strong rationale for the development of gene therapy for limb-girdle muscular dystrophy.</description><subject>Adeno-associated virus</subject><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Cell Membrane Permeability</subject><subject>Cricetinae</subject><subject>Cytoskeletal Proteins - genetics</subject><subject>Cytoskeletal Proteins - therapeutic use</subject><subject>Dependovirus - genetics</subject><subject>Genetic Therapy - methods</subject><subject>Genetic Vectors</subject><subject>Histamine - therapeutic use</subject><subject>Humans</subject><subject>Infectious Diseases</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Membrane Glycoproteins - therapeutic use</subject><subject>Metabolic Diseases</subject><subject>Molecular Medicine</subject><subject>Muscular Dystrophy, Animal - therapy</subject><subject>Neurosciences</subject><subject>Perfusion</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>Recombinant Proteins - therapeutic use</subject><subject>Sarcoglycans</subject><subject>Sarcolemma - pathology</subject><issn>1078-8956</issn><issn>1546-170X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1TAQhS1ERUvLKyAvgF3o2EmceImq8iNVYgFI7KKxM-l1ldjBdgr3FfrU9dXtAlZ447HmO2fkOYxdCHgvoO4vu6bWz9iZaBtViQ5-Pi81dH3V61adspcp3QFADa1-wU4FSJC6Vmfs4VtGMxOPlHKImF3wPEw874gnjDbcznuLntuwrDP94c7zcZ9yDOvOWb5syRbtSnHaEo38t8s7vnMp4-I8cfQjx-JcxMZ59JnjSD5UmFKwDnNR3LuIM78nW4ZfsJMJ50Svnu5z9uPj9ferz9XN109frj7cVLauZa46bczUTL1SYydGCU0jSbaSNIDRnUJoG9NBU-oGjSzvDielegKrDAgj63P27ui7xvBrK_8eFpcszTN6ClsalFa9Elr_FxSdLEccwDdH0MaQUqRpWKNbMO4HAcMhnOEQTsFeP_ltZqHxL-iYRgHeHoFUWv6W4nAXtujLMv41egSKx5eP</recordid><startdate>19990401</startdate><enddate>19990401</enddate><creator>Greelish, James P.</creator><creator>Su, Leonard T.</creator><creator>Lankford, Edward B.</creator><creator>Burkman, James M.</creator><creator>Chen, Haiyan</creator><creator>Konig, Stephane K.</creator><creator>Mercier, Isabelle M.</creator><creator>Desjardins, Philippe R.</creator><creator>Mitchell, Marilyn A.</creator><creator>Zheng, Xiang guang</creator><creator>Leferovich, John</creator><creator>Gao, Guang Ping</creator><creator>Balice-Gordon, Rita J.</creator><creator>Wilson, James M.</creator><creator>Stedman, Hansell H.</creator><general>Nature Publishing Group US</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>19990401</creationdate><title>Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector</title><author>Greelish, James P. ; Su, Leonard T. ; Lankford, Edward B. ; Burkman, James M. ; Chen, Haiyan ; Konig, Stephane K. ; Mercier, Isabelle M. ; Desjardins, Philippe R. ; Mitchell, Marilyn A. ; Zheng, Xiang guang ; Leferovich, John ; Gao, Guang Ping ; Balice-Gordon, Rita J. ; Wilson, James M. ; Stedman, Hansell H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-79bbf4f866d71d20442e252e900b976a054b704b974ab26a07af668e0c6b01b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adeno-associated virus</topic><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Cell Membrane Permeability</topic><topic>Cricetinae</topic><topic>Cytoskeletal Proteins - genetics</topic><topic>Cytoskeletal Proteins - therapeutic use</topic><topic>Dependovirus - genetics</topic><topic>Genetic Therapy - methods</topic><topic>Genetic Vectors</topic><topic>Histamine - therapeutic use</topic><topic>Humans</topic><topic>Infectious Diseases</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Membrane Glycoproteins - therapeutic use</topic><topic>Metabolic Diseases</topic><topic>Molecular Medicine</topic><topic>Muscular Dystrophy, Animal - therapy</topic><topic>Neurosciences</topic><topic>Perfusion</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>Recombinant Proteins - therapeutic use</topic><topic>Sarcoglycans</topic><topic>Sarcolemma - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Greelish, James P.</creatorcontrib><creatorcontrib>Su, Leonard T.</creatorcontrib><creatorcontrib>Lankford, Edward B.</creatorcontrib><creatorcontrib>Burkman, James M.</creatorcontrib><creatorcontrib>Chen, Haiyan</creatorcontrib><creatorcontrib>Konig, Stephane K.</creatorcontrib><creatorcontrib>Mercier, Isabelle M.</creatorcontrib><creatorcontrib>Desjardins, Philippe R.</creatorcontrib><creatorcontrib>Mitchell, Marilyn A.</creatorcontrib><creatorcontrib>Zheng, Xiang guang</creatorcontrib><creatorcontrib>Leferovich, John</creatorcontrib><creatorcontrib>Gao, Guang Ping</creatorcontrib><creatorcontrib>Balice-Gordon, Rita J.</creatorcontrib><creatorcontrib>Wilson, James M.</creatorcontrib><creatorcontrib>Stedman, Hansell H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Greelish, James P.</au><au>Su, Leonard T.</au><au>Lankford, Edward B.</au><au>Burkman, James M.</au><au>Chen, Haiyan</au><au>Konig, Stephane K.</au><au>Mercier, Isabelle M.</au><au>Desjardins, Philippe R.</au><au>Mitchell, Marilyn A.</au><au>Zheng, Xiang guang</au><au>Leferovich, John</au><au>Gao, Guang Ping</au><au>Balice-Gordon, Rita J.</au><au>Wilson, James M.</au><au>Stedman, Hansell H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector</atitle><jtitle>Nature medicine</jtitle><stitle>Nat Med</stitle><addtitle>Nat Med</addtitle><date>1999-04-01</date><risdate>1999</risdate><volume>5</volume><issue>4</issue><spage>439</spage><epage>443</epage><pages>439-443</pages><issn>1078-8956</issn><eissn>1546-170X</eissn><abstract>Limb-girdle muscular dystrophies 2C–F represent a family of autosomal recessive diseases caused by defects in sarcoglycan genes 1 . The cardiomyopathic hamster is a naturally occurring model for limb-girdle muscular dystrophy caused by a primary deficiency in δ-sarcoglycan 2 , 3 , 4 , 5 . We show here that acute sarcolemmal disruption occurs in this animal model during forceful muscle contraction. A recombinant adeno-associated virus vector encoding human δ-sarcoglycan conferred efficient and stable genetic reconstitution in the adult cardiomyopathic hamster when injected directly into muscle. A quantitative assay demonstrated that vector-transduced muscle fibers are stably protected from sarcolemmal disruption; there was no associated inflammation or immunologic response to the vector-encoded protein. Efficient gene transduction with rescue of the sarcoglycan complex in muscle fibers of the distal hindlimb was also obtained after infusion of recombinant adeno-associated virus into the femoral artery in conjunction with histamine-induced endothelial permeabilization. This study provides a strong rationale for the development of gene therapy for limb-girdle muscular dystrophy.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>10202936</pmid><doi>10.1038/7439</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1078-8956
ispartof Nature medicine, 1999-04, Vol.5 (4), p.439-443
issn 1078-8956
1546-170X
language eng
recordid cdi_proquest_miscellaneous_69686199
source MEDLINE; Springer Nature - Complete Springer Journals; Springer Nature - Connect here FIRST to enable access
subjects Adeno-associated virus
Animals
Biomedical and Life Sciences
Biomedicine
Cancer Research
Cell Membrane Permeability
Cricetinae
Cytoskeletal Proteins - genetics
Cytoskeletal Proteins - therapeutic use
Dependovirus - genetics
Genetic Therapy - methods
Genetic Vectors
Histamine - therapeutic use
Humans
Infectious Diseases
Membrane Glycoproteins - genetics
Membrane Glycoproteins - therapeutic use
Metabolic Diseases
Molecular Medicine
Muscular Dystrophy, Animal - therapy
Neurosciences
Perfusion
Rats
Rats, Inbred F344
Recombinant Proteins - therapeutic use
Sarcoglycans
Sarcolemma - pathology
title Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T20%3A18%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stable%20restoration%20of%20the%20sarcoglycan%20complex%20in%20dystrophic%20muscle%20perfused%20with%20histamine%20and%20a%20recombinant%20adeno-associated%20viral%20vector&rft.jtitle=Nature%20medicine&rft.au=Greelish,%20James%20P.&rft.date=1999-04-01&rft.volume=5&rft.issue=4&rft.spage=439&rft.epage=443&rft.pages=439-443&rft.issn=1078-8956&rft.eissn=1546-170X&rft_id=info:doi/10.1038/7439&rft_dat=%3Cproquest_cross%3E17222219%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17222219&rft_id=info:pmid/10202936&rfr_iscdi=true